Infectious Diseases Therapeutics Market Research Reports

"...... $ 1380.7 million in 2022 and is anticipated to reach US$ 1346.9 million by 2029, witnessing a CAGR of -0.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes......."

"...... e called as Fragyl Orvagil, Trichazol, Metronid, etc. LPI (LP Information)' newest research report, the "Metronidazole Industry Forecast" looks at past sales and reviews total world Metronidazole sales in 2022, providing a comprehensive analys......"

"...... br /> Due to the COVID-19 pandemic, the global Cephalosporin market size is estimated to be worth US$ 1380.7 million in 2022 and is forecast to a readjusted size of US$ 1346.9 million by 2029 with a CAGR of -0.3% during the forecast period 2023-2029......"

"...... e called as Fragyl Orvagil, Trichazol, Metronid, etc. According to our (Global Info Research) latest study, the global Metronidazole market size was valued at USD 116.3 million in 2022 and is forecast to a readjusted size of USD 112.4 mi......"

"...... e called as Fragyl Orvagil, Trichazol, Metronid, etc. Market Analysis and Insights: Global Metronidazole Market Due to the COVID-19 pandemic, the global Metronidazole market size is estimated to be worth US$ 113 million in 2022 ......"

"...... bal Cephalosporin market size was valued at USD 1420.7 million in 2022 and is forecast to a readjusted size of USD 1390.5 million by 2029 with a CAGR of -0.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered ......"

"...... formed business decisions regarding Ceftriaxone. The Ceftriaxone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast dat......"

"...... tal Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Drugs In Development, 2022, provides an overview of the Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) pipeline l......"

"...... lococcus aureus (VRSA) Infections - Drugs In Development, 2022, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline landscape. Vancomycin resistant staphylococcus infecti......"

"...... ides an overview of the Tinea Pedis (Athlete Foot) (Infectious Disease) pipeline landscape. Athlete's foot, also known as tinea pedis, is a common foot infection caused by fungi called dermatophytes. Symptoms include dry flaking skin on ......"